Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Get Premium

Register

Sign In

EUR/USD

1.2217

-0.0019

-0.16%

GBP/USD

1.3852

-0.0040

-0.29%

USD/JPY

110.83

-0.1945

-0.18%

USD/CHF

0.9640

0.0051

0.53%

EUR/GBP

0.8820

0.0012

0.14%

USD/CAD

1.2498

0.0088

0.71%

NZD/USD

0.7275

-0.0019

-0.27%

EUR/JPY

135.41

-0.4460

-0.33%

EUR/CHF

1.1779

0.0046

0.39%

AC Immune Sa

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
13.14+0.08+0.61%Vol 23 9911Y Perf 3.87%
Jan 19th, 2018 16:00
BID13.07 ASK13.14
Open13.20 Previous Close13.06
Pre-Market- After-Trading-
 - -%  - -%
Target Price
23.00 
Analyst Rating
Strong Buy 1.00
Potencial %
75.04 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)748 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
92.10 
Earnings Date
16th Mar 2018

Today's Price Range

13.0013.21

 

52wk Range

6.0313.75

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
9.50%
3 Months
11.83%
6 Months
61.82%
1 Year
3.87%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ACIU13.140.08000.61
AAPL178.46-0.8000-0.45
GOOG1 137.517.72000.68
MSFT90.00-0.1000-0.11
XOM87.15-0.2800-0.32
WFC64.220.27000.42
JNJ147.360.44000.30
FB181.291.49000.83
GE16.26-0.5100-3.04
JPM113.01-0.2500-0.22
...

TickerPriceChg.%52 Week High
MAT16.145.9831.60
HBI23.205.4525.73
NKE67.214.8467.24
KSS67.544.1567.55
UA12.853.8826.25
PM108.923.66123.55
LOW104.953.54105.60
WYN126.993.47127.96
LB50.693.4163.10
PBCT20.083.3520.12
FL50.213.3377.86
AMG212.003.25213.86
HCA93.013.2293.32
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 14.60
Current Ratio 14.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -102.30
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-664.90
EBITDA Margin-655.80
Pre-tax Profit Margin-
Profit Margin-42.10
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 6.64
PS Ratios 192.02
Price to Cash Flow 35.80
Price to Free Cash Flow -24.70
Cash Flow Per Share -0.64
Price to Tangible Book6.64
Book Value per Share2.03
Enterprise Value (in ths.)647 183
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -27.25
Return on Assets (5Y Avg) -
ROA last 12 Months -24.66
Return on Capital (5Y Avg) -
ROC last 12 Months -27.04
Return on invested Capital Q -7.52
Return on invested Capital Y-9.80
Assets Turnover0.00
Receivables Turnover2.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 934
Revenue per Share 0.07
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2017 QR-0.0910.00Positive
12/2017 FY-0.6316.00Positive
3/2018 QR-0.1084.38Positive
12/2018 FY-0.57--
Next Report Date16th Mar 2018
Estimated EPS Next Report-0.09
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume23 991
Shares Outstanding (in ths.)56 920
Trades Count117
Dollar Volume198 421
Avg. Volume53 199
Avg. Weekly Volume43 858
Avg. Monthly Volume66 610
Avg. Quarterly Volume87 972

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

75%25%

Bearish Bullish

83%17%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x